Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

PRP shows potential for treating female hair loss, but more research needed.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

3D-printed microneedles improve drug delivery by being precise, cost-effective, and less invasive.

A special hydrogel helps heal skin without scars and regrows hair.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

Finasteride reduces new brain cells in male mice, possibly causing depression.

A natural steroid in the body may protect against eye damage in glaucoma.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.